Sofinnova Investments’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-80,300
Closed -$47.6M – 84
2026
Q1
$47.6M Buy
+80,300
New +$40M 1.81% 17
2025
Q4
– Sell
-97,100
Closed -$40.7M – 72
2025
Q3
$40.7M Buy
+97,100
New +$32.7M 2.23% 16
2021
Q4
– Sell
-94,500
Closed -$17.4M – 79
2021
Q3
$17.4M Buy
+94,500
New +$18.6M 1.03% 22

Other funds holding UTHR

Sofinnova Investments's UTHR Position: Q3 2026 in Review

Sofinnova Investments reduced its United Therapeutics (UTHR) stake by 52% in Q3 2026, selling an estimated $20.7M and leaving 36,491 shares worth $19.8M. The position accounts for 0.86% of the portfolio, ranked #26.

Sofinnova Investments first reported a position in UTHR in Q3 2019 and has held it in 20 quarters since. The position peaked at $94.9M in Q1 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Sofinnova Investments held 36,491 shares of United Therapeutics worth $19.8M as of Q3 2026.
  • Sofinnova Investments sold 39,998 United Therapeutics shares in Q3 2026, an estimated $20.7M.
  • United Therapeutics made up 0.86% of Sofinnova Investments's portfolio in Q3 2026, its #26 holding.
  • Sofinnova Investments first reported a position in United Therapeutics in Q3 2019 and has held it in 20 quarters since.
  • Sofinnova Investments's United Therapeutics position peaked at $94.9M in Q1 2026.
  • 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Sofinnova Investments's 13F filing for Q3 2026, filed 16 Nov 2026.